Location: Dallas, TX
CIK: 0001617201 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 14, 2020
Total Value: $228M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ZBH | ZIMMER BIOMET HLDGS INC | 130,000 | $19.46M | 8.5% | $110.07 | +19.3% | COM | 98956P102 |
| QURE | UNIQURE NV | 237,500 | $17.02M | 7.5% | $59.89 | -8.3% | SHS | N90064101 |
| — | ARENA PHARMACEUTICALS INC | 328,129 | $14.9M | 6.5% | $43.81 | — | COM NEW | 040047607 |
| KURA | KURA ONCOLOGY INC | 1,036,000 | $14.24M | 6.3% | $16.30 | -9.1% | COM | 50127T109 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 161,195 | $14.2M | 6.2% | $82.53 | +6.6% | COM | 91307C102 |
| — | REATA PHARMACEUTICALS INC | 62,900 | $12.86M | 5.6% | $46.26 | — | CL A | 75615P103 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 388,600 | $10.76M | 4.7% | $12.80 | +77.7% | COM | 462260100 |
| ACIU | AC IMMUNE SA | 1,242,843 | $10.59M | 4.6% | $5.81 | +14.7% | SHS | H00263105 |
| MGTX | MEIRAGTX HOLDINGS PLC | 517,844 | $10.37M | 4.6% | $21.14 | -19.0% | COM | G59665102 |
| — | ARQULE INC | 450,326 | $8.989M | 3.9% | $10.31 | — | COM | 04269E107 |
| CNC | CENTENE CORP DEL | 142,800 | $8.978M | 3.9% | $55.81 | -2.8% | COM | 15135B101 |
| ALDX | ALDEYRA THERAPEUTICS INC | 1,428,277 | $8.298M | 3.6% | $7.50 | -23.0% | COM | 01438T106 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 92,737 | $7.841M | 3.4% | $85.05 | -11.2% | COM | 09061G101 |
| URGN | UROGEN PHARMA LTD | 217,686 | $7.264M | 3.2% | $38.49 | -29.1% | COM | M96088105 |
| — | ARENA PHARMACEUTICALS INC | 142,400 | $6.468M | 2.8% | — | — | Call | 040047907 |
| — | ALBIREO PHARMA INC | 247,178 | $6.283M | 2.8% | $29.61 | — | COM | 01345P106 |
| NVST | ENVISTA HLDGS CORP | 165,000 | $4.891M | 2.1% | $28.45 | 0.0% | COM | 29415F104 |
| PSNL | PERSONALIS INC | 406,673 | $4.433M | 1.9% | $14.12 | -26.3% | COM | 71535D106 |
| ANAB | ANAPTYSBIO INC | 234,823 | $3.816M | 1.7% | $23.65 | 0.0% | COM | 032724106 |
| IMVT | IMMUNOVANT INC | 224,702 | $3.566M | 1.6% | $11.17 | 0.0% | COM | 45258J102 |
| ORGO | ORGANOGENESIS HLDGS INC | 617,836 | $2.972M | 1.3% | $6.34 | 0.0% | COM | 68621F102 |
| EOLS | EVOLUS INC | 236,939 | $2.884M | 1.3% | $14.10 | 0.0% | COM | 30052C107 |
| — | CATALYST BIOSCIENCES INC | 391,894 | $2.669M | 1.2% | $9.00 | — | COM NEW | 14888D208 |
| — | STRONGBRIDGE BIOPHARMA PLC | 1,258,224 | $2.63M | 1.2% | $3.69 | — | SHS USD | G85347105 |
| — | R1 RCM INC | 200,000 | $2.596M | 1.1% | $8.93 | — | COM | 749397105 |
| EVH | EVOLENT HEALTH INC | 279,390 | $2.528M | 1.1% | $8.12 | 0.0% | CL A | 30050B101 |
| CI | CIGNA CORP NEW | 11,293 | $2.309M | 1.0% | $179.32 | -6.5% | COM | 125523100 |
| — | MOLECULAR TEMPLATES INC | 160,883 | $2.25M | 1.0% | $5.90 | — | COM | 608550109 |
| CUE | CUE BIOPHARMA INC | 137,628 | $2.185M | 1.0% | $10.47 | 0.0% | COM | 22978P106 |
| — | ALLAKOS INC | 20,700 | $1.974M | 0.9% | — | — | Put | 01671P950 |
| — | PARATEK PHARMACEUTICALS INC | 450,000 | $1.814M | 0.8% | $4.03 | — | COM | 699374302 |
| TNET | TRINET GROUP INC | 28,104 | $1.591M | 0.7% | $54.24 | 0.0% | COM | 896288107 |
| — | KEZAR LIFE SCIENCES INC | 320,000 | $1.283M | 0.6% | $4.01 | — | COM | 49372L100 |
| — | TELIGENT INC NEW | 1,484,527 | $632K | 0.3% | $3.21 | — | COM | 87960W104 |
| — | AXSOME THERAPEUTICS INC | 6,000 | $620K | 0.3% | — | — | Put | 05464T954 |
| MIST | MILESTONE PHARMACEUTICALS IN | 38,481 | $616K | 0.3% | $17.77 | 0.0% | COM | 59935V107 |
| BMY | BRISTOL MYERS SQUIBB CO | 8,100 | $520K | 0.2% | $37.62 | +20.1% | COM | 110122108 |
| — | APOLLO ENDOSURGERY INC | 159,336 | $454K | 0.2% | $2.85 | — | COM | 03767D108 |